Form 4 for TLSI TriSalus Life Sciences, Inc.
Accepted 2026-02-23 00:00:00 ET · period of report 2026-02-23 · accession 0001628280-26-010603 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-02-23 | 2026-02-23 | TLSI | Szela Mary T | CEO, Pres, Dir | P - Purchase | $4.10 | +30.5K | 773.3K | +4% | +$125.0K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-02-23 | P | A | 30,487 | $4.10 | 773,289 | D | — | — |